| __timestamp | Catalent, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1229100000 | 520990000000 |
| Thursday, January 1, 2015 | 1215500000 | 535405000000 |
| Friday, January 1, 2016 | 1260500000 | 558755000000 |
| Sunday, January 1, 2017 | 1420800000 | 495921000000 |
| Monday, January 1, 2018 | 1710800000 | 659690000000 |
| Tuesday, January 1, 2019 | 1712900000 | 1089764000000 |
| Wednesday, January 1, 2020 | 2111000000 | 994308000000 |
| Friday, January 1, 2021 | 2646000000 | 1106846000000 |
| Saturday, January 1, 2022 | 3188000000 | 1244072000000 |
| Sunday, January 1, 2023 | 3216000000 | 1431505000000 |
| Monday, January 1, 2024 | 3428000000 | 1431505000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, cost efficiency is a critical metric for success. Takeda Pharmaceutical Company Limited and Catalent, Inc. are two industry titans that have demonstrated contrasting trends in their cost of revenue from 2014 to 2024. Takeda, a global leader, has seen its cost of revenue soar by approximately 175% over the decade, peaking at 1.43 trillion in 2023. In contrast, Catalent, a key player in drug development and delivery, has experienced a more modest increase of around 180%, reaching 3.43 billion in 2024. This divergence highlights the scale and operational differences between the two companies. While Takeda's vast operations drive higher costs, Catalent's focused approach allows for more controlled expenditure. As the industry continues to innovate, understanding these dynamics is crucial for investors and stakeholders alike.
Cost of Revenue Trends: AbbVie Inc. vs Catalent, Inc.
Cost of Revenue Comparison: Pfizer Inc. vs Takeda Pharmaceutical Company Limited
Cost Insights: Breaking Down GSK plc and Catalent, Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs CRISPR Therapeutics AG
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Biogen Inc. and Catalent, Inc.'s Expenses
Cost of Revenue Comparison: Catalent, Inc. vs CRISPR Therapeutics AG
Cost of Revenue Trends: Catalent, Inc. vs Perrigo Company plc
Cost Insights: Breaking Down Catalent, Inc. and Bausch Health Companies Inc.'s Expenses
Cost Insights: Breaking Down Catalent, Inc. and Vericel Corporation's Expenses